Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PHSYX vs HRTS overlap: 62% of top holdings shared

Bottom line

How much do PHSYX and HRTS overlap?

62% of their top holdings overlap by weight. 16 securities appear in both funds' top 25, making up 69.7% of PHSYX's assets and 59.3% of HRTS's. They share a meaningful core but differ in the rest of the portfolio.

PHSYX holds far more positions (115 vs 45), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

PHSYXHRTS
Weight overlap (top 25)62%
Shared holdings16
Weight in shared holdings69.7%59.3%
Total positions11545
Expense ratio0.79%0.75%
Holdings as ofMay 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Holdings PHSYX and HRTS have in common

Holding% of PHSYX% of HRTSOverlap
Eli Lilly & Co.13.15%11.52%11.52%
Johnson & Johnson8.46%3.59%3.59%
UnitedHealth Group, Inc.6.93%5.24%5.24%
AbbVie, Inc.6.05%2.40%2.40%
Novartis AG5.13%3.38%3.38%
Merck & Co., Inc.4.88%4.27%4.27%
AstraZeneca plc4.67%4.00%4.00%
Thermo Fisher Scientific, Inc.4.50%3.97%3.97%
Edwards Lifesciences Corp.2.80%1.75%1.75%
Gilead Sciences, Inc.2.63%3.43%2.63%
McKesson Corp.2.14%1.71%1.71%
Vertex Pharmaceuticals, Inc.1.97%2.93%1.97%
Novo Nordisk A/S1.90%5.24%1.90%
Bristol-Myers Squibb Co.1.75%2.09%1.75%
Dexcom, Inc.1.64%1.92%1.64%
Amgen, Inc.1.11%1.91%1.11%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PHSYX

  1. Intuitive Surgical, Inc. — 4.04%
  2. Sanofi SA — 3.23%
  3. Roche Holding AG — 2.79%
  4. CVS Health Corp. — 2.74%
  5. Cardinal Health, Inc. — 2.12%
  6. Boston Scientific Corp. — 1.80%
  7. Hoya Corp. — 1.52%
  8. Putnam Short Term Investment Fund — 1.35%
  9. HCA Healthcare, Inc. — 1.18%

Only in HRTS

  1. Roche Holding AG — 4.50%
  2. Revolution Medicines Inc — 3.33%
  3. Danaher Corp — 2.66%
  4. Abbott Laboratories — 2.61%
  5. Bridgebio Pharma Inc — 2.59%
  6. Cytokinetics Inc — 2.52%
  7. Teva Pharmaceutical Industries — 2.06%
  8. Medtronic PLC — 1.88%
  9. Regeneron Pharmaceuticals Inc — 1.67%

Asset mix

Asset typePHSYXHRTS
Stocks98.2%99.2%
Other1.4%—
Cash & short-term funds0.6%0.7%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Country mix

CountryPHSYXHRTS
US76.2%74.9%
CH7.9%7.9%
DK2.4%7.0%
GB6.4%4.0%
FR3.2%—
JP2.4%1.3%
IL—2.1%
IE—1.9%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do PHSYX and HRTS overlap?
About 62% by weight. 16 securities appear in both funds' top 25 holdings; they make up 69.7% of PHSYX's assets and 59.3% of HRTS's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PHSYX and HRTS have in common?
The largest shared holdings are Eli Lilly & Co., UnitedHealth Group, Inc., Merck & Co., Inc., AstraZeneca plc, Thermo Fisher Scientific, Inc..
Should I own both PHSYX and HRTS?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PHSYX or HRTS?
PHSYX is broader, with 115 positions versus 45 for HRTS. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.